PAMA
Top Five Articles on 360Dx Last Week: FDA Guidance for COVID Tests; SALSA Reintroduction; and More
Last week, readers were most interested in a story about guidance issued by FDA for test developers seeking full market authorization for COVID-19 tests.
Congress Reintroduces SALSA, Taking up PAMA Reform Once Again
A top priority for the lab industry, the bill was reintroduced this week by bipartisan groups of legislators in both the House and Senate.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
Lawmakers are still wrangling over whether to include these two key lab industry bills in an end-of-year spending package due to pass next week.
Many hospital labs don't have the ability to effectively report lab price data, which could undermine SALSA's impact on PAMA's price-setting process.
Oct 20, 2022
Jul 24, 2022
Jul 21, 2022
Jul 6, 2022
Dec 23, 2021
Dec 21, 2021
Dec 10, 2021
Congress Delays PAMA Cuts and Reporting Requirements
Jun 23, 2021
Jul 18, 2019
Jun 18, 2019
Nursing Home Labs Feeling PAMA Pinch
May 16, 2019
Feb 26, 2019